Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / American Depositary Shares, each representing five-hundred Ordinary Shares
-
Shares outstanding
-
11,387,333
-
Total 13F shares
-
2,479,478
-
Share change
-
+2,151,403
-
Total reported value
-
$17,070,899
-
Price per share
-
$6.89
-
Number of holders
-
22
-
Value change
-
+$14,797,378
-
Number of buys
-
13
-
Number of sells
-
5
Institutional Holders of KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA) as of Q4 2025
As of 31 Dec 2025,
KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,479,478 shares.
The largest 10 holders included
Alyeska Investment Group, L.P., Stonepine Capital Management, LLC, Bleichroeder LP, Velan Capital Investment Management LP, Point72 Asset Management, L.P., Empery Asset Management, LP, CORSAIR CAPITAL MANAGEMENT, L.P., ROYAL BANK OF CANADA, Westside Investment Management, Inc., and BARCLAYS PLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.